ADvantage Therapeutics's ^Investor

Developing therapies to treat neurodegenerative conditionsADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are currently preparing for clinical trials in Europe and in the Therapeutics - A new Vantage on Alzheimer’s /?